Theriva Biologics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TOVX | TRAW | APVO | ALGS | ATORX.ST | ABVC | |
|---|---|---|---|---|---|---|
| Market cap | 8.72M | 4.13M | 2.90M | 31.35M | 38.18M | 26.69M |
| P/E (TTM) | 0.3 | — | 0.0 | — | — | — |
| Forward P/E | -1.0 | -0.1 | -0.1 | -1.0 | -0.1 | -2.3 |
| Price/book | 0.7 | 2.4 | 0.3 | 1.0 | 0.3 | 2.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −29.63% | −86.70% | −94.82% | −29.30% | −99.44% | −64.79% |
| Today | +4.40% | −11.06% | +0.74% | +5.68% | 0.00% | +1.51% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All TOVX news ›Theriva Biologics proposes 500M authorized shares
ASHFORD HOSPITALITY TRUST ANNOUNCES $17 MILLION ADVISORY FEE WAIVER, SHARE PURCHASE COMMITMENT FROM ASHFORD INC. AND TERMINATION OF ATM PROGRAM Supermicro Provides First Quarter of Fiscal Year 2027 Preliminary Business Update Netflix…
Theriva Biologics puts up to 16.2M warrant shares to vote
Netflix Reports Q3 2026 Earnings: Revenue Rises 12% to $12.87 Billion, Operating Margin 34.6% INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science Peraso Receives Production Order Exceeding $2.0…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.